Jost Fischer insider trades: AEON Biopharma (AEON) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jost reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 21, 2025 | AEON | ↑ Buy | 60,000 | $0.49 | $29K | Direct | May 23, 2025 (2d) |
| May 20, 2025 | AEON | ↑ Buy | 110,000 | $0.50 | $55K | Direct | May 21, 2025 (1d) |
| Nov 29, 2011 | SIRO | ↑ Buy | 50 | $42.76 | $2K | Direct | Nov 29, 2011 (0d) |
| Nov 23, 2011 | SIRO | ↑ Buy | 25,000 | $39.93 | $998K | Direct | Nov 25, 2011 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AEON insiders
Open-market trades in the last 12 months
About Jost Fischer's insider trades
Jost Fischer is a director at AEON Biopharma (AEON). Since Nov 23, 2011, Jost has reported 4 open-market purchases worth $1.1M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AEON insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.